The Cancer Center of Hawaii-Liliha — Honolulu, Hawaii

The Cancer Center of Hawaii-Liliha is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

The Cancer Center of Hawaii-Liliha has participated in 207 clinical trials with 110 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prostate Carcinoma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Center of Hawaii-Liliha?

The Cancer Center of Hawaii-Liliha has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Center of Hawaii-Liliha conducted?

The Cancer Center of Hawaii-Liliha has 207 clinical trials on record, with 110 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prostate Carcinoma.

Is The Cancer Center of Hawaii-Liliha accredited by Crixeo Health?

The Cancer Center of Hawaii-Liliha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Cancer Center of Hawaii-Liliha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.